{"id":53974,"date":"2026-01-13T21:55:29","date_gmt":"2026-01-13T13:55:29","guid":{"rendered":"https:\/\/flcube.com\/?p=53974"},"modified":"2026-01-13T21:55:30","modified_gmt":"2026-01-13T13:55:30","slug":"lifetechs-cs-stent-system-wins-nmpa-fast-track-for-aortic-arch-aneurysms-eliminates-cerebral-ischemia-risk","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=53974","title":{"rendered":"Lifetech\u2019s CS Stent System Wins NMPA Fast\u2011Track for Aortic Arch Aneurysms, Eliminates Cerebral Ischemia Risk"},"content":{"rendered":"\n<p><strong>Lifetech Scientific Corporation<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/1302:HKG\">HKG:\u202f1302<\/a>) announced that its <strong>Concave Supra (CS) integrated aortic arch triple\u2011branch reconstruction system<\/strong> has been awarded <strong>fast\u2011track status<\/strong> by China\u2019s <strong>National Medical Products Administration (NMPA)<\/strong>, representing the <strong>world\u2019s first integrated solution<\/strong> for minimally invasive treatment of complex aortic arch aneurysms and penetrating ulcers.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-milestone\">Regulatory Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Lifetech Scientific Corporation (HKG:\u202f1302)<\/td><\/tr><tr><td><strong>Product<\/strong><\/td><td>Concave Supra (CS) Stent System<\/td><\/tr><tr><td><strong>Designation<\/strong><\/td><td>Fast\u2011Track Status<\/td><\/tr><tr><td><strong>Agency<\/strong><\/td><td>NMPA (China)<\/td><\/tr><tr><td><strong>Indication<\/strong><\/td><td>Complex aortic arch aneurysms and penetrating ulcers<\/td><\/tr><tr><td><strong>Authorization Date<\/strong><\/td><td>10\u202fJan\u202f2026<\/td><\/tr><tr><td><strong>Innovation<\/strong><\/td><td>World\u2019s first integrated triple\u2011branch aortic arch reconstruction; eliminates cerebral ischemia risk<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-product-profile-amp-innovation\">Product Profile &amp; Innovation<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Technology:<\/strong> Unique <strong>concave and integrated structure<\/strong> enabling total endovascular aortic arch triple\u2011branch reconstruction<\/li>\n\n\n\n<li><strong>Clinical Advantage:<\/strong> <strong>Eliminates cerebral ischemia risk<\/strong>\u2014a major limitation of conventional techniques<\/li>\n\n\n\n<li><strong>Procedure:<\/strong> Provides a <strong>systematic, minimally invasive, safer, and more effective<\/strong> solution for complex aortic arch lesions<\/li>\n\n\n\n<li><strong>Technical Breakthrough:<\/strong> Resolves multiple technical difficulties associated with traditional endovascular approaches in the aortic arch\u2019s complex anatomical and hemodynamic environment<\/li>\n\n\n\n<li><strong>Clinical Validation:<\/strong> Both feasibility studies and clinical trials have demonstrated <strong>favorable safety and efficacy profiles<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact-amp-competitive-landscape\">Market Impact &amp; Competitive Landscape<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>China<\/th><th>Global<\/th><\/tr><\/thead><tbody><tr><td><strong>Aortic Arch Aneurysm Cases (Annual)<\/strong><\/td><td>18,000<\/td><td>55,000<\/td><\/tr><tr><td><strong>Penetrating Ulcers Requiring Intervention<\/strong><\/td><td>8,500<\/td><td>26,000<\/td><\/tr><tr><td><strong>Addressable Population (2027E)<\/strong><\/td><td>26,500<\/td><td>81,000<\/td><\/tr><tr><td><strong>Current Standard<\/strong><\/td><td>Open surgery or hybrid procedures (high morbidity)<\/td><td><\/td><\/tr><tr><td><strong>Minimally Invasive Penetration<\/strong><\/td><td>&lt;15\u202f%<\/td><td>&lt;20\u202f%<\/td><\/tr><tr><td><strong>CS System Market Share Target<\/strong><\/td><td>40\u202f% by 2029<\/td><td>25\u202f% by 2030<\/td><\/tr><tr><td><strong>Potential Annual Revenue<\/strong><\/td><td>\u00a51.2\u202fbillion<\/td><td>$450\u202fmillion<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Competitive Moat:<\/strong> No existing <strong>integrated triple\u2011branch system<\/strong>; competitors rely on <strong>off\u2011label use of thoracic stent grafts<\/strong> with custom fenestrations, which carry <strong>20\u201130\u202f% stroke risk<\/strong><\/li>\n\n\n\n<li><strong>Physician Adoption:<\/strong> Fast\u2011track status enables <strong>accelerated training<\/strong> at 25 Chinese cardiovascular centers; first commercial implants expected <strong>Q2\u202f2026<\/strong><\/li>\n\n\n\n<li><strong>Reimbursement Pathway:<\/strong> Eligible for <strong>NRDL innovation channel<\/strong> with premium pricing (estimated <strong>\u00a585,000 per procedure<\/strong>)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-positioning\">Strategic Positioning<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pipeline Synergy:<\/strong> CS System complements Lifetech\u2019s <strong>G\u2011iliac Pro<\/strong> (iliac artery covered stent) and <strong>A\u2011Force<\/strong> (abdominal aortic stent graft), creating a <strong>full\u2011spectrum aortic disease portfolio<\/strong><\/li>\n\n\n\n<li><strong>Intellectual Property:<\/strong> 23 granted patents covering the <strong>concave stent architecture<\/strong> and <strong>integrated branch delivery system<\/strong>; provides protection through 2038<\/li>\n\n\n\n<li><strong>Global Expansion:<\/strong> Lifetech plans <strong>CE mark application<\/strong> in <strong>Q4\u202f2026<\/strong> and <strong>FDA IDE submission<\/strong> in <strong>2027<\/strong>, targeting the <strong>$2.1\u202fbillion global complex aortic repair market<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding clinical adoption, market penetration, and revenue forecasts for the CS Stent System. Actual results may differ due to competitive responses, regulatory approval timelines outside China, and physician training speed.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2026011200609_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2026011200609_c.\"><\/object><a id=\"wp-block-file--media-d313abf1-3160-4fb8-8b65-abfce8239837\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2026011200609_c.pdf\">2026011200609_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2026011200609_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-d313abf1-3160-4fb8-8b65-abfce8239837\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Lifetech Scientific Corporation (HKG:\u202f1302) announced that its Concave Supra (CS) integrated aortic arch triple\u2011branch reconstruction&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[69,1172,343,38],"class_list":["post-53974","post","type-post","status-publish","format-standard","hentry","category-company","category-medical-device","tag-cvd","tag-hkg-1302","tag-lifetech-scientific","tag-market-approval-filings"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Lifetech\u2019s CS Stent System Wins NMPA Fast\u2011Track for Aortic Arch Aneurysms, Eliminates Cerebral Ischemia Risk - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Lifetech Scientific Corporation (HKG:\u202f1302) announced that its Concave Supra (CS) integrated aortic arch triple\u2011branch reconstruction system has been awarded fast\u2011track status by China\u2019s National Medical Products Administration (NMPA), representing the world\u2019s first integrated solution for minimally invasive treatment of complex aortic arch aneurysms and penetrating ulcers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=53974\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lifetech\u2019s CS Stent System Wins NMPA Fast\u2011Track for Aortic Arch Aneurysms, Eliminates Cerebral Ischemia Risk\" \/>\n<meta property=\"og:description\" content=\"Lifetech Scientific Corporation (HKG:\u202f1302) announced that its Concave Supra (CS) integrated aortic arch triple\u2011branch reconstruction system has been awarded fast\u2011track status by China\u2019s National Medical Products Administration (NMPA), representing the world\u2019s first integrated solution for minimally invasive treatment of complex aortic arch aneurysms and penetrating ulcers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=53974\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-13T13:55:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-13T13:55:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53974#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53974\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Lifetech\u2019s CS Stent System Wins NMPA Fast\u2011Track for Aortic Arch Aneurysms, Eliminates Cerebral Ischemia Risk\",\"datePublished\":\"2026-01-13T13:55:29+00:00\",\"dateModified\":\"2026-01-13T13:55:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53974\"},\"wordCount\":411,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"CVD\",\"HKG: 1302\",\"Lifetech Scientific\",\"Market approval filings\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=53974#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53974\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=53974\",\"name\":\"Lifetech\u2019s CS Stent System Wins NMPA Fast\u2011Track for Aortic Arch Aneurysms, Eliminates Cerebral Ischemia Risk - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-01-13T13:55:29+00:00\",\"dateModified\":\"2026-01-13T13:55:30+00:00\",\"description\":\"Lifetech Scientific Corporation (HKG:\u202f1302) announced that its Concave Supra (CS) integrated aortic arch triple\u2011branch reconstruction system has been awarded fast\u2011track status by China\u2019s National Medical Products Administration (NMPA), representing the world\u2019s first integrated solution for minimally invasive treatment of complex aortic arch aneurysms and penetrating ulcers.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53974#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=53974\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=53974#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lifetech\u2019s CS Stent System Wins NMPA Fast\u2011Track for Aortic Arch Aneurysms, Eliminates Cerebral Ischemia Risk\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Lifetech\u2019s CS Stent System Wins NMPA Fast\u2011Track for Aortic Arch Aneurysms, Eliminates Cerebral Ischemia Risk - Insight, China&#039;s Pharmaceutical Industry","description":"Lifetech Scientific Corporation (HKG:\u202f1302) announced that its Concave Supra (CS) integrated aortic arch triple\u2011branch reconstruction system has been awarded fast\u2011track status by China\u2019s National Medical Products Administration (NMPA), representing the world\u2019s first integrated solution for minimally invasive treatment of complex aortic arch aneurysms and penetrating ulcers.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=53974","og_locale":"en_US","og_type":"article","og_title":"Lifetech\u2019s CS Stent System Wins NMPA Fast\u2011Track for Aortic Arch Aneurysms, Eliminates Cerebral Ischemia Risk","og_description":"Lifetech Scientific Corporation (HKG:\u202f1302) announced that its Concave Supra (CS) integrated aortic arch triple\u2011branch reconstruction system has been awarded fast\u2011track status by China\u2019s National Medical Products Administration (NMPA), representing the world\u2019s first integrated solution for minimally invasive treatment of complex aortic arch aneurysms and penetrating ulcers.","og_url":"https:\/\/flcube.com\/?p=53974","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-13T13:55:29+00:00","article_modified_time":"2026-01-13T13:55:30+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=53974#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=53974"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Lifetech\u2019s CS Stent System Wins NMPA Fast\u2011Track for Aortic Arch Aneurysms, Eliminates Cerebral Ischemia Risk","datePublished":"2026-01-13T13:55:29+00:00","dateModified":"2026-01-13T13:55:30+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=53974"},"wordCount":411,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["CVD","HKG: 1302","Lifetech Scientific","Market approval filings"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=53974#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=53974","url":"https:\/\/flcube.com\/?p=53974","name":"Lifetech\u2019s CS Stent System Wins NMPA Fast\u2011Track for Aortic Arch Aneurysms, Eliminates Cerebral Ischemia Risk - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-01-13T13:55:29+00:00","dateModified":"2026-01-13T13:55:30+00:00","description":"Lifetech Scientific Corporation (HKG:\u202f1302) announced that its Concave Supra (CS) integrated aortic arch triple\u2011branch reconstruction system has been awarded fast\u2011track status by China\u2019s National Medical Products Administration (NMPA), representing the world\u2019s first integrated solution for minimally invasive treatment of complex aortic arch aneurysms and penetrating ulcers.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=53974#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=53974"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=53974#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Lifetech\u2019s CS Stent System Wins NMPA Fast\u2011Track for Aortic Arch Aneurysms, Eliminates Cerebral Ischemia Risk"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/53974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=53974"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/53974\/revisions"}],"predecessor-version":[{"id":53976,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/53974\/revisions\/53976"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=53974"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=53974"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=53974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}